» Articles » PMID: 32321906

Baicalin Inhibits Cell Proliferation and Inflammatory Cytokines Induced by Tumor Necrosis Factor α (TNF-α) in Human Immortalized Keratinocytes (HaCaT) Human Keratinocytes by Inhibiting the STAT3/Nuclear Factor Kappa B (NF-κB) Signaling Pathway

Overview
Journal Med Sci Monit
Date 2020 Apr 24
PMID 32321906
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Baicalin is a flavone isolated from the root of Scutellaria baicalensis and is used in traditional Chinese medicine. Psoriasis is a persistent and recurrent chronic inflammatory skin disease that is characterized by inflammation and increased proliferation of keratinocytes. This study aimed to investigate the effects of baicalin on HaCaT immortalized human keratinocytes in vitro and the molecular mechanisms involved. MATERIAL AND METHODS HaCaT keratinocytes were cultured in increasing concentrations of baicalin at 6.25 μM, 12.5 μM, and 25 μM. The in vitro model of psoriasis was established using HaCaT cells treated with tumor necrosis factor-alpha (TNF-alpha). The MTT assay was used to asses cell viability and apoptosis. Western blot was used to measure the expression of Bcl-2, Bax, pro-caspase-3, and cleaved caspase-3, and enzyme-linked immunosorbent assay (ELISA) was performed to detect inflammatory cytokines. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to detect the levels of STAT3 and p65 mRNA. RESULTS Baicalin reduced cell viability and induced apoptosis of HaCaT human keratinocytes in a dose-dependent manner. Increased cell viability and the expression of inflammatory cytokines by HaCaT cells induced by TNF-alpha were significantly inhibited by baicalin. Baicalin significantly inhibited the activation of the STAT3/NF-kappaB pathway in HaCaT cells stimulated by TNF-alpha. CONCLUSIONS Baicalin inhibited the proliferation and expression of inflammatory cytokines in HaCaT immortalized human keratinocytes in vitro through the inhibition of the STAT3/NF-kappaB signaling pathway.

Citing Articles

Development and Evaluation of Methotrexate and Baicalin-Loaded Nanolipid Carriers for Psoriasis Treatment.

Sohail S, Arshad S, Khalid S, Dar M, Iqbal K, Sohail H Turk J Pharm Sci. 2024; 21(4):327-339.

PMID: 39224396 PMC: 11589095. DOI: 10.4274/tjps.galenos.2023.71242.


The Influence of Phytoconstituents for the Management of Antipsoriatic Activity in Various Animal Models.

Yadav R, Yadav T, Upadhayay A, Alam M, Dubey G, Kumar V Antiinflamm Antiallergy Agents Med Chem. 2024; 23(4):215-229.

PMID: 39082165 DOI: 10.2174/0118715230320581240711063558.


Celastrus orbiculatus Extract Inhibits Immune Inflammatory Thrombotic State of B-Lymphoma.

Zhu M, Shi Q, Ni J, Wu W, Sun X, Sun M Chin J Integr Med. 2024; 30(11):1018-1026.

PMID: 38782853 DOI: 10.1007/s11655-024-4102-0.


Banzhilian formula alleviates psoriasis-like lesions the LCN2/MMP-9 axis based on transcriptome analysis.

Xing M, Yan X, Guo J, Li W, Li Z, Dong C Front Pharmacol. 2023; 14:1055363.

PMID: 36950008 PMC: 10025347. DOI: 10.3389/fphar.2023.1055363.


Oxyresveratrol Inhibits TNF-α-Stimulated Cell Proliferation in Human Immortalized Keratinocytes (HaCaT) by Suppressing AKT Activation.

Wikan N, Hankittichai P, Thaklaewphan P, Potikanond S, Nimlamool W Pharmaceutics. 2022; 14(1).

PMID: 35056961 PMC: 8781909. DOI: 10.3390/pharmaceutics14010063.


References
1.
Fu S, Xu L, Li S, Qiu Y, Liu Y, Wu Z . Baicalin suppresses NLRP3 inflammasome and nuclear factor-kappa B (NF-κB) signaling during Haemophilus parasuis infection. Vet Res. 2016; 47(1):80. PMC: 4977663. DOI: 10.1186/s13567-016-0359-4. View

2.
Zhang J, Zhang H, Deng X, Zhang Y, Xu K . Baicalin protects AML-12 cells from lipotoxicity via the suppression of ER stress and TXNIP/NLRP3 inflammasome activation. Chem Biol Interact. 2017; 278:189-196. DOI: 10.1016/j.cbi.2017.10.010. View

3.
Li C, Lin G, Zuo Z . Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. Biopharm Drug Dispos. 2011; 32(8):427-45. DOI: 10.1002/bdd.771. View

4.
Antoniou E, Koutsounas I, Damaskos C, Koutsounas S . Remission of Psoriasis in a Patient with Hepatocellular Carcinoma Treated with Sorafenib. In Vivo. 2016; 30(5):677-80. View

5.
Takeshita J, Grewal S, Langan S, Mehta N, Ogdie A, Van Voorhees A . Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol. 2017; 76(3):377-390. PMC: 5731650. DOI: 10.1016/j.jaad.2016.07.064. View